<DOC>
	<DOCNO>NCT01878279</DOCNO>
	<brief_summary>In propose study , investigator carry novel research evaluate symptomatic asymptomatic daily oral herpes simplex virus ( HSV ) shed rate copy number child without HIV . Study Objectives : 1 . To evaluate frequency oral HSV reactivation HIV-infected uninfected child Secondary Objectives : 2 . To determine acceptability perform daily oral swab child age 3-12</brief_summary>
	<brief_title>HSV Oral Reactivation Children</brief_title>
	<detailed_description />
	<criteria>age &gt; 3 â‰¤12 year old parental/guardian consent child 's assent must obtain participant parent/guardian must able comply study procedure For HIVinfected group : Positive HIV serology either ELISA x 2 , ELISA + WB PCR test age &lt; 3 &gt; 12 year old Acute illness opinion investigator make enrollment trial unfeasible ( include active tuberculosis , malaria opportunistic infection require treatment ) coenrollment therapeutic/intervention trial ( observational trial enrollment permit ) . Stable coadministration medication permit ( e.g . bactrim ) For HIVinfected child ; receive eligible antiretroviral ( ART ) therapy local standard</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>